These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35140322)

  • 1. Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members.
    Samangooei M; Farjam M; Etemadifar M; Taheri A; Meshkibaf MH; Movahedi B; Niknam Z; Noroozi S
    Sci Rep; 2022 Feb; 12(1):2160. PubMed ID: 35140322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing-remitting multiple sclerosis patients and their first-degree family.
    Samangooei M; Farjam M; Niknam Z; Etemadifar M; Meshkibaf MH; Noroozi S
    Metab Brain Dis; 2021 Oct; 36(7):1929-1934. PubMed ID: 34115275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
    Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
    Røsjø E; Steffensen LH; Jørgensen L; Lindstrøm JC; Šaltytė Benth J; Michelsen AE; Aukrust P; Ueland T; Kampman MT; Torkildsen Ø; Holmøy T
    J Neurol; 2015 Dec; 262(12):2713-21. PubMed ID: 26429571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
    Stein MS; Ward GJ; Butzkueven H; Kilpatrick TJ; Harrison LC
    Mol Med; 2018 May; 24(1):27. PubMed ID: 30134801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH; Rolf L; Broen K; Hupperts R; Damoiseaux J; Smolders J
    J Steroid Biochem Mol Biol; 2016 Nov; 164():254-257. PubMed ID: 26598277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D
    Smolders J; Mimpen M; Oechtering J; Damoiseaux J; van den Ouweland J; Hupperts R; Kuhle J
    Acta Neurol Scand; 2020 Jan; 141(1):77-80. PubMed ID: 31657006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?
    Mado H; Adamczyk-Sowa M; Bartman W; Wierzbicki K; Tadeusiak B; Sowa P
    Clin Neurol Neurosurg; 2021 Jul; 206():106700. PubMed ID: 34030079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
    Liggett T; Melnikov A; Tilwalli S; Yi Q; Chen H; Replogle C; Feng X; Reder A; Stefoski D; Balabanov R; Levenson V
    J Neurol Sci; 2010 Mar; 290(1-2):16-21. PubMed ID: 20064646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma copeptin levels in patients with multiple sclerosis.
    Koseoglu M; Ozben S; Gozubatik-Celik G; Tutuncu M; Kucuksayan E; Hanikoğlu A; Atakli D; Ozben T
    J Clin Neurosci; 2020 Aug; 78():143-146. PubMed ID: 32345514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do multiple sclerosis and migraine coexist?
    Hamamcı M; Göcmen AY; Say B; Alpua M; Badem ND; Ergün U; Ertuğrul İnan L
    Mult Scler Relat Disord; 2020 May; 40():101946. PubMed ID: 31982663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain.
    Sylvestre DA; Slupsky CM; Aviv RI; Swardfager W; Taha AY
    Brain Res; 2020 Apr; 1732():146589. PubMed ID: 31816317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
    Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
    J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis.
    Kraszula L; Jasińska A; Eusebio M; Kuna P; Głąbiński A; Pietruczuk M
    Neurol Neurochir Pol; 2012; 46(1):22-8. PubMed ID: 22426759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Level of Caspase-1 in the Serum of Relapsing-remitting Multiple Sclerosis (RRMS) Patients.
    Beheshti M; Salehi Z; Abolfazli R; Shirzad H; Izad M
    Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):534-538. PubMed ID: 33463121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
    Grau-López L; Granada ML; Raïch-Regué D; Naranjo-Gómez M; Borràs-Serres FE; Martínez-Cáceres E; Ramo-Tello C
    BMC Neurol; 2012 Sep; 12():103. PubMed ID: 23006125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-23 plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
    Shajarian M; Alsahebfosoul F; Etemadifar M; Sedaghat N; Shahbazi M; Firouzabadi FP; Dezashibi HM
    Immunol Invest; 2015; 44(1):36-44. PubMed ID: 25083738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS).
    Mashayekhi F; Hadipour E; Shabani S; Salehi Z
    Clin Neurol Neurosurg; 2024 Feb; 237():108161. PubMed ID: 38325038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.